clinical_trials
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
Confidence88·multiple reportsImportance90NP-EVT-20261103-A791027
Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.
Read the original at the primary source
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
Jason Mast · 11/3/2026, 8:53:20 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —